{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Research+blood+draw&page=39", "query": { "intervention": "Research blood draw", "page": 39 }, "page_size": 10 }, "pagination": { "page": 39, "page_size": 10, "total_count": 1005, "total_pages": 101, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Research+blood+draw&page=40&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Research+blood+draw&page=38&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-16T07:08:33.567Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04377997", "title": "Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cardiovascular Diseases", "COVID-19" ], "interventions": [ { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2020-05-15", "completion_date": "2022-06-01", "has_results": false, "last_update_posted_date": "2022-02-22", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04377997" }, { "nct_id": "NCT06030297", "title": "Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Peripheral Neuropathy" ], "interventions": [ { "name": "Diode Laser fiber type Selective Stimulator", "type": "PROCEDURE" }, { "name": "ZTlido 1.8 % Topical System", "type": "DRUG" }, { "name": "PeriCam PSI NR", "type": "DIAGNOSTIC_TEST" }, { "name": "Medoc Quantitative Sensory Testing", "type": "DIAGNOSTIC_TEST" }, { "name": "Inactive Topical System", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2023-09-01", "completion_date": "2026-02-09", "has_results": false, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 2, "location_summary": "Palo Alto, California • Salt Lake City, Utah", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06030297" }, { "nct_id": "NCT04713657", "title": "Beta-blocker Administration for Cardiomyocyte Division", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Tetralogy of Fallot", "Double Outlet Right Ventricle" ], "interventions": [ { "name": "N-thymidine", "type": "OTHER" }, { "name": "Urine Collection", "type": "OTHER" }, { "name": "Echocardiogram", "type": "PROCEDURE" }, { "name": "Cardiac MRI (CMR)", "type": "PROCEDURE" }, { "name": "Propranolol Hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Physical Exam", "type": "PROCEDURE" }, { "name": "Specimen Collection", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE", "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Days", "maximum_age": "60 Days", "sex": "ALL", "summary": "30 Days to 60 Days" }, "enrollment_count": 40, "start_date": "2022-12-16", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2025-11-18", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 3, "location_summary": "New York, New York • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04713657" }, { "nct_id": "NCT01753895", "title": "Mercury Versus Automated Blood Pressure Monitoring", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy Volunteers" ], "interventions": [], "intervention_types": [], "sponsor": "Rockefeller University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 156, "start_date": "2012-12", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2014-05-06", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01753895" }, { "nct_id": "NCT01505569", "title": "Auto Transplant for High Risk or Relapsed Solid or CNS Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ewing's Family Tumors", "Renal Tumors", "Hepatoblastoma", "Rhabdomyosarcoma", "Soft Tissue Sarcoma", "Primary Malignant Brain Neoplasms", "Retinoblastoma", "Medulloblastoma", "Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)", "Atypical Teratoid/Rhabdoid Tumor (AT/RT)", "CNS Tumors", "Germ Cell Tumors" ], "interventions": [ { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Mesna", "type": "DRUG" }, { "name": "G-CSF", "type": "BIOLOGICAL" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Thiotepa", "type": "DRUG" }, { "name": "Autologous stem cell infusion", "type": "BIOLOGICAL" }, { "name": "Radiation", "type": "RADIATION" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Leukapheresis", "type": "PROCEDURE" }, { "name": "Anti-seizure prophylaxis", "type": "DRUG" }, { "name": "Ursodiol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "RADIATION", "PROCEDURE" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "70 Years", "sex": "ALL", "summary": "Up to 70 Years" }, "enrollment_count": 44, "start_date": "2011-10-20", "completion_date": "2024-02-01", "has_results": false, "last_update_posted_date": "2024-02-26", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01505569" }, { "nct_id": "NCT05978141", "title": "A Registry for People With T-cell Lymphoma", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "T-cell Lymphoma", "NK-Cell Lymphoma", "T-cell Prolymphocytic Leukemia", "T-cell Large Granular Lymphocytic Leukemia", "Chronic Lymphoproliferative Disorder of NK Cells", "Aggressive NK-cell Leukemia", "Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)", "Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood", "Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form", "Hydroa Vacciniforme-Like Lymphoproliferative Disorder", "Adult T-cell Leukemia/Lymphoma", "Extranodal NK/T-cell Lymphoma, Nasal Type", "Enteropathy-associated T-cell Lymphoma", "Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma", "Intestinal T-Cell Lymphoma, Not Otherwise Specified", "Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract", "Hepatosplenic T-cell Lymphoma", "Subcutaneous Panniculitis-Like T-Cell Lymphoma", "Mycosis Fungoides", "Sezary Syndrome", "Primary Cutaneous Anaplastic Large Cell Lymphoma", "Primary Cutaneous T-cell Lymphoma", "Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma", "Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma", "Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Angioimmunoblastic T-cell Lymphoma", "Follicular T-Cell Lymphoma", "Nodal Peripheral T-Cell Lymphoma With TFH Phenotype", "Anaplastic Large Cell Lymphoma, ALK-Positive", "Anaplastic Large Cell Lymphoma, ALK-negative", "Breast Implant-Associated Anaplastic Large Cell Lymphoma" ], "interventions": [ { "name": "Optional Blood Sample and Nail Sample", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2023-07-27", "completion_date": "2030-07-27", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 26, "location_summary": "Duarte, California • San Diego, California • San Francisco, California + 20 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05978141" }, { "nct_id": "NCT00995527", "title": "Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy Volunteers" ], "interventions": [], "intervention_types": [], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2009-09-30", "completion_date": "2014-06-25", "has_results": false, "last_update_posted_date": "2017-10-06", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00995527" }, { "nct_id": "NCT05844124", "title": "Impact of Different Exercise Programs on Knee OA", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis", "Knee Osteoarthritis", "Arthritis", "Joint Diseases", "Musculoskeletal Diseases", "Rheumatic Diseases" ], "interventions": [ { "name": "Exercise for Knee Osteoarthritis Recommendations (Control group)", "type": "OTHER" }, { "name": "Exercise for Knee Osteoarthritis -(LBPP supported low-load treadmill Walking)", "type": "OTHER" }, { "name": "Exercise for Knee Osteoarthritis - (Aquatic Walking)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Shirley Ryan AbilityLab", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2023-04-01", "completion_date": "2025-07-31", "has_results": false, "last_update_posted_date": "2025-07-01", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05844124" }, { "nct_id": "NCT05721248", "title": "STOP-HER2: Stopping Trastuzumab in HER2+ MBC", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Metastatic Breast Cancer", "HER2-positive Breast Cancer" ], "interventions": [ { "name": "Cessation of anti-HER2 treatment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 82, "start_date": "2023-04-19", "completion_date": "2036-06", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 13, "location_summary": "Phoenix, Arizona • Washington D.C., District of Columbia • Jacksonville, Florida + 10 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Foxborough", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05721248" }, { "nct_id": "NCT06692933", "title": "Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Interaction" ], "interventions": [ { "name": "Cannabidiol in the form of hemp", "type": "DRUG" }, { "name": "Clopidogrel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "21 Years to 64 Years" }, "enrollment_count": 24, "start_date": "2024-06-20", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-10-16T07:08:33.567Z", "location_count": 1, "location_summary": "Spokane, Washington", "locations": [ { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06692933" } ] }